LAVENTATUG
UNII XKA49HSW7G

Substance Identification & Data

This profile provides standardized clinical and technical data for Laventatug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XKA49HSW7G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3009829-91-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
XKA49HSW7G
CAS Registry Number
3009829-91-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LAVENTATUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C215292
National Cancer Institute reference terminology for clinical and research data.
INN ID
13502
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Laventatug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LAVENTATUG

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-450) (VH (HOMO SAPIENS IGHV1-69-2*01 (88.5%) -(IGHD) -IGHJ6*05 (81.8%) K120>Q (112), A127>S (119), CDR-IMGT (8.8.13) (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)), (223-219')-DISULFIDE WITH LKAPPA LIGHT CHAIN HUMANIZED (1'-219') (V-KAPPA (HOMO SAPIENS IGKV2-29*02 (89.0%) -IGKJ2*01 (91.7%) Q120>G (105'), CDR-IMGT (11.3.9) (27'-37'.55'-57'.94'-102')) (1'-112') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (158'), V101 (196')) (113'-219')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-S, GLYCOFORM ALFA
IMMUNOGLOBULIN G1, ANTI-(HUMAN ZINC TRANSPORTER ZIP6) (HUMAN-MUS MUSCULUS MONOCLONAL BRY812 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BRY812 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SLC39A6 (SOLUTE CARRIER FAMILY 39 MEMBER 6, SOLUTE CARRIER FAMILY 39 (METAL ION TRANSPORTER) MEMBER 6, SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER) MEMBER 6, LIV-1), ZIP6), HUMANIZED MONOCLONAL ANTIBODY (LAVENTATUG)
LAVENTATUG [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus